Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

Erstveröffentlichung
2019Authors
Schaefer, Guido
Hoffmann, Christian
Arasteh, Keikawus
Schuermann, Dirk
Stephan, Christoph
Wissenschaftlicher Artikel
Published in
AIDS Research and Therapy ; 16 (2019), 1. - Art.-Nr. 34. - ISSN 1742-6405
Link to publication
https://dx.doi.org/10.1186/s12981-019-0250-2Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: Late presentation | Opportunistic infections | Pneumocystis jirovecii | PCP | Cerebral toxoplasmosis HIV | Diagnosis | Treatment | LATE DIAGNOSIS | INITIATION | START | CONSEQUENCES | INDIVIDUALS | COMBINATION | EFFICACY | EARLIER | SAFETY | TIME[DDC subject group]: DDC 610 / Medicine & health